Skip to content

PlaDuo System

by shenb Co., Ltd.

PlaDuo System is a nitrogen plasma skin surface treatment system (FDA Class II; FDA product code GEI, Electrosurgical, Cutting & Coagulation & Accessories) made by shenb Co., Ltd., cleared under FDA 510(k) K201735 on 14 Dec 2020 and listed in FDA GUDID since 28 Dec 2020 (UDI-DI 08800017100159), active as of 21 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 21 Oct 2026

Documents

510(k) K201735

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 21 Oct 2026.

Regulatory status

as of registry sync 21 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number08800017100159 UDI-DI Date28 Dec 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK201735 Date14 Dec 2020DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K201735 decided 14 Dec 2020 Active
  • FDA GUDID UDI-DI 08800017100159 listed 28 Dec 2020 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K201735
  2. Listed FDA GUDID 08800017100159

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Generic name
Nitrogen plasma skin surface treatment system
Model / reference
PlaDuo
Primary DI / UDI-DI
08800017100159
510(k) Number
FDA product code
GEI
GMDN term
Nitrogen plasma skin surface treatment system
Device class
Class II
Regulation number
878.4400
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code GEI (Electrosurgical, Cutting & Coagulation & Accessories).

Other devices from shenb Co., Ltd.

See all devices from shenb Co., Ltd. →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)